288 related articles for article (PubMed ID: 34794327)
1. Clinical Features, Immunotherapy, and Outcomes of Anti-Leucine-Rich Glioma-Inactivated-1 Encephalitis.
Huang X; Fan C; Gao L; Li L; Ye J; Shen H
J Neuropsychiatry Clin Neurosci; 2022; 34(2):141-148. PubMed ID: 34794327
[TBL] [Abstract][Full Text] [Related]
2. Clinical features of 28 cases of anti
Feng J; Li J; Xie Y; Lü Y; Bi F; Zhou J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Mar; 48(3):386-396. PubMed ID: 37164922
[TBL] [Abstract][Full Text] [Related]
3. Neurological, psychiatric, and sleep investigations after treatment of anti-leucine-rich glioma-inactivated protein 1 (LGI1) encephalitis in Spain: a prospective cohort study.
Muñoz-Lopetegi A; Guasp M; Prades L; Martínez-Hernández E; Rosa-Justícia M; Patricio V; Armangué T; Rami L; Borràs R; Castro-Fornieles J; Compte A; Gaig C; Santamaria J; Dalmau J;
Lancet Neurol; 2024 Mar; 23(3):256-266. PubMed ID: 38365378
[TBL] [Abstract][Full Text] [Related]
4. Clinical features of nine cases of leucine-rich glioma inactivated 1 protein antibody-associated encephalitis.
Li Y; Song F; Liu W; Wang Y
Acta Neurol Belg; 2021 Aug; 121(4):889-897. PubMed ID: 32232701
[TBL] [Abstract][Full Text] [Related]
5. A case of pediatric anti-leucine-rich glioma inactivated 1 encephalitis with faciobrachial dystonic seizure.
Jang S; Kim SY; Kim WJ; Chae JH; Kim KJ; Lim BC
Brain Dev; 2023 Jun; 45(6):348-353. PubMed ID: 36858863
[TBL] [Abstract][Full Text] [Related]
6. Clinical analysis of leucine-rich glioma inactivated-1 protein antibody associated with limbic encephalitis onset with seizures.
Li Z; Cui T; Shi W; Wang Q
Medicine (Baltimore); 2016 Jul; 95(28):e4244. PubMed ID: 27428233
[TBL] [Abstract][Full Text] [Related]
7. Clinical features of anti-leucine-rich glioma-inactivated 1 encephalitis in northeast China.
Zhao Q; Sun L; Zhao D; Chen Y; Li M; Lu Y; Li G; Lin W
Clin Neurol Neurosurg; 2021 Apr; 203():106542. PubMed ID: 33706063
[TBL] [Abstract][Full Text] [Related]
8. Clinical features of patients with anti-leucine-rich glioma inactivated-1 protein associated encephalitis: a Chinese case series.
Yang X; Li AN; Zhao XH; Liu XW; Wang SJ
Int J Neurosci; 2019 Aug; 129(8):754-761. PubMed ID: 30621547
[No Abstract] [Full Text] [Related]
9. Clinical characteristics of Leucine-rich glioma-inactivated protein 1 antibody-mediated autoimmune encephalitis in a 6-year-old girl: case report and literature reviews.
Chen L; Su T; Liu Y
BMC Neurol; 2023 Jun; 23(1):253. PubMed ID: 37391712
[TBL] [Abstract][Full Text] [Related]
10. Whole-brain metabolic pattern analysis in patients with anti-leucine-rich glioma-inactivated 1 (LGI1) encephalitis.
Mo J; Dong W; Cui T; Chen C; Shi W; Hu W; Zhang C; Wang X; Zhang K; Shao X
Eur J Neurol; 2022 Aug; 29(8):2376-2385. PubMed ID: 35514068
[TBL] [Abstract][Full Text] [Related]
11. Anti-leucine-rich Glioma Inactivated-1 Encephalitis Associated with Essential Thrombocythemia.
Yuan X; Man X; Zhang J; Sun J; Liang J; Ma H; Tao S; Guo D; Liu L
Intern Med; 2020; 59(2):271-275. PubMed ID: 31941873
[TBL] [Abstract][Full Text] [Related]
12. What Is Different about Teratoma-Associated Anti-LGI1 Encephalitis? A Long-Term Clinical and Neuroimaging Case Series.
Li C; Cai HB; Zhao X; Xi XC; Zhou Q; Luo HY; Tang ZP; Kang HC; Kirsch HE
Eur Neurol; 2022; 85(6):437-445. PubMed ID: 35896086
[TBL] [Abstract][Full Text] [Related]
13. [Ictal electroencephalography (EEG) activity and cerebral blood flow dynamics as potential pathological indicators: a case of anti-leucine-rich glioma-inactivated 1 protein (LGI1) encephalitis].
Ishibashi H; Neshige S; Aoki S; Ueno H; Iida K; Maruyama H
Rinsho Shinkeigaku; 2020 Nov; 60(11):778-785. PubMed ID: 33115994
[TBL] [Abstract][Full Text] [Related]
14. A Case of Anti-Leucine-Rich Glioma-Inactivated Protein 1 (Anti-LGI1) Limbic Encephalitis With New-Onset Panic Attacks.
Coleman B; Sawhney K; LaPenna P
Cureus; 2024 Apr; 16(4):e58406. PubMed ID: 38756253
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Cognitive Deficits and Structural Hippocampal Damage in Encephalitis With Leucine-Rich, Glioma-Inactivated 1 Antibodies.
Finke C; Prüss H; Heine J; Reuter S; Kopp UA; Wegner F; Then Bergh F; Koch S; Jansen O; Münte T; Deuschl G; Ruprecht K; Stöcker W; Wandinger KP; Paul F; Bartsch T
JAMA Neurol; 2017 Jan; 74(1):50-59. PubMed ID: 27893017
[TBL] [Abstract][Full Text] [Related]
16. Long-term evolution and prognostic factors of epilepsy in limbic encephalitis with LGI1 antibodies.
Guery D; Cousyn L; Navarro V; Picard G; Rogemond V; Bani-Sadr A; Shor N; Joubert B; Muñiz-Castrillo S; Honnorat J; Rheims S
J Neurol; 2022 Sep; 269(9):5061-5069. PubMed ID: 35595970
[TBL] [Abstract][Full Text] [Related]
17. LGI1 antibody encephalitis: acute treatment comparisons and outcome.
Rodriguez A; Klein CJ; Sechi E; Alden E; Basso MR; Pudumjee S; Pittock SJ; McKeon A; Britton JW; Lopez-Chiriboga AS; Zekeridou A; Zalewski NL; Boeve BF; Day GS; Gadoth A; Burkholder D; Toledano M; Dubey D; Flanagan EP
J Neurol Neurosurg Psychiatry; 2022 Mar; 93(3):309-315. PubMed ID: 34824144
[TBL] [Abstract][Full Text] [Related]
18. Clinical characteristics and short-term prognosis of LGI1 antibody encephalitis: a retrospective case study.
Li W; Wu S; Meng Q; Zhang X; Guo Y; Cong L; Cong S; Zheng D
BMC Neurol; 2018 Jul; 18(1):96. PubMed ID: 29980179
[TBL] [Abstract][Full Text] [Related]
19. Anti-Leucine-rich glioma-inactivated Protein 1 antibody-associated encephalitis complicated by minimal change nephrotic syndrome: a case report.
Zhang WJ; Gao N
Eur Rev Med Pharmacol Sci; 2022 Oct; 26(20):7556-7560. PubMed ID: 36314326
[TBL] [Abstract][Full Text] [Related]
20. Electroencephalographic findings in antileucine-rich glioma-inactivated 1 (LGI1) autoimmune encephalitis: A systematic review.
Roberto KT; Espiritu AI; Fernandez MLL; Gutierrez JC
Epilepsy Behav; 2020 Nov; 112():107462. PubMed ID: 32971385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
